ACIU is a leading researcher in the field of dementia, with major deals with big pharma. Read more here.Read full newsRead More
S&P 500 earnings don't start for another 3 - 4 weeks and are almost an afterthought now. The forward 4-quarter estimate slid this week to $221.49 from last week's $221.55.Read full newsRead More
I have been fascinated by the evolution of batting averages within the baseball community and think there are real parallels to the ETF ecosystem.Read full newsRead More
The Fed began raising interest rates one year ago, on March 17, 2022, and the U.S. economy is not in recession. Milton Friedman famously found that the time lags are long and variable.Read full newsRead More
Could the consensus view of a 'no recession' scenario be wrong? As portfolio managers, this is the question we ask ourselves daily.Read full newsRead More
Trading in sub-dollar securities has certainly increased in recent years and is a trend to keep a close eye on.Read full newsRead More
Fast facts on iShares Global Consumer Staples ETF, an international alternative to XLP. Click here for more on KXI and its sector.Read full newsRead More
Even after doubling, Meta could soar much more but there's a catch. Without a dividend, Meta isn't expected to outperform most companies. Read more here.Read full newsRead More
Following the record 2022, the shares of W&T Offshore are sliding on falling oil and gas prices. Lear more about WTI here.Read full newsRead More
With the US government backstopping its banks, and as WTI recovers, there is an opportunity for trading two-time gain magnifier GUSH ETF. Click here to learn how.Read full newsRead More
Allegro is a good Buy candidate despite the string run-up in the year-to-date. Click here to read more.Read full newsRead More
The majority of the top ten holdings in the ProShares Online Retail ETF have a positive outlook. See why ONLN ETF offers a perfect Buy & Hold opportunity.Read full newsRead More
IHI ETF invests in large-cap medical devices stocks in US. Learn more about iShares U.S. Medical Devices ETF here.Read full newsRead More
Catalyst watch for the week of March 19. In light of recent events in the banking industry, what could result from the FOMC meeting on March 21, 22? Foot Locker and Nike reports earnings.Read full newsRead More
We have decided to provide an update on all of the primary players among cannabis REITs: IIPR, NLCP, AFCG, and REFI. Click to see our review of these stocks.Read full newsRead More
Arkema has lower exposure to EU (thanks also to M&A) and a solid balance sheet to navigate a weaker 2023. Read more to see why we rate the stock a Buy.Read full newsRead More
HEICO reported an impressive backlog increase recently and expects sales growth in 2023 driven by product demand, mergers, and acquisitions. Read more here.Read full newsRead More
CME has an asset-light business model allowing it to pay a steadily rising quarterly dividend and an additional annual special dividend. Read more here.Read full newsRead More
Insulet achieved another remarkable fiscal year, driven by the successful adoption of Omnipod 5, which is being used by growing diabetic patients globally. Read more here.Read full newsRead More
Huron Consulting is a $1.3B market cap professional services firm that works in Healthcare, Education, and Commercial end markets. Learn why HURN is the best play in the industry.Read full newsRead More